missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human FXR2 (aa 377-453) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (92%), Rat (92%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-82809 (PA5-82809. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Fragile X syndrome is caused by the absence of the fragile X mental-retardation protein (FMRP). FMRP is the archetype of a class of cytoplasmic mRNA-binding proteins that includes the fragile X-related 1 and 2 proteins (FXR1 and FXR2). The fragile X-related proteins FXR1 and FXR2 contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins.
Specifications
Specifications
| Accession Number | P51116 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 9513 |
| Name | Human FXR2 (aa 377-453) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | FMR1 autosomal homolog 2; FMR1L2; fragile x mental retardation gene 2, autosomal homolog; fragile x mental retardation syndrome-related protein 2; fragile x mental retardation, autosomal homolog 2; fragile x mental retardation-related protein 2; fragile X-mental retardation 1-like 2; Fxr2; Fxr2h; FXR2P |
| Common Name | FXR2 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction